Ahmed A. Kolkailah, MD, MSc
Harvard University
H-index: 13
North America-United States
Top articles of Ahmed A. Kolkailah, MD, MSc
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Hypoglycemia and Cardiovascular Outcomes in the CARMELINA and CAROLINA Trials of Linagliptin: A Secondary Analysis of Randomized Clinical Trials | JAMA cardiology | Nikolaus Marx Ahmed A Kolkailah Julio Rosenstock Odd Erik Johansen Mark E Cooper | 2024/2/1 |
Automated External Defibrillator Use After Out-of-Hospital Cardiac Arrest at Recreational Facilities | JAMA Internal Medicine | Ahmed A Kolkailah Paul S Chan Qiang Li Anezi Uzendu Mirza S Khan | 2024/2/1 |
Use of sodium-glucose cotransporter 2 inhibitors and glucagonlike peptide-1 receptor agonists in patients with diabetes and cardiovascular disease in community practice | bmj | Björn Pasternak Peter Ueda Björn Eliasson Ann-Marie Svensson Stefan Franzén | 2019/8/29 |
Longitudinal trends in cardiovascular risk factor profiles and complications among patients hospitalized for COVID-19 infection: results from the American Heart Association … | Circulation: Cardiovascular Quality and Outcomes | Eric J Hall Colby R Ayers Ahmed A Kolkailah Christine Rutan Jason Walchok | 2023/5 |
Uptake of non-statin lipid-lowering therapies for secondary prevention in community practice | Journal of Clinical Lipidology | Corey K Bradley Ahmed A Kolkailah Nishant P Shah Courtney B Page Eric D Peterson | 2023/5/1 |
Ertugliflozin and hospitalization for heart failure across the spectrum of pre-trial ejection fraction: post-hoc analyses of the VERTIS CV trial | European heart journal | Ambarish Pandey Ahmed A Kolkailah Francesco Cosentino Christopher P Cannon Robert C Frederich | 2023/12/21 |
Effects of Ertugliflozin on Kidney Outcomes in Patients With Heart Failure at Baseline in the Evaluation of Ertugliflozin Efficacy and Safety Cardiovascular Outcomes (VERTIS CV … | Kidney International Reports | David ZI Cherney Francesco Cosentino Darren K McGuire Ahmed A Kolkailah Samuel Dagogo-Jack | 2023/4/1 |
Automated External Defibrillator Utilization After Out-of-Hospital Cardiac Arrest at Recreational Facilities in the United States | Circulation | Ahmed A Kolkailah Paul S Chan Qiang Li Anezi Uzendu Mirza Khan | 2023/11/7 |
Effects of once‐weekly subcutaneous semaglutide on coronary artery disease outcomes in patients with type 2 diabetes with or at high risk for cardiovascular disease: Insights … | Diabetes, Obesity and Metabolism | Ahmed A Kolkailah Ildiko Lingvay Idit Dobrecky‐Mery Alona Aharonovich Jens‐Peter David | 2023/4 |
Gaps in guideline-based lipid-lowering therapy for secondary prevention in the United States: a retrospective cohort study of 322 153 patients | Circulation: Cardiovascular Quality and Outcomes | Ann Marie Navar Ahmed A Kolkailah Anand Gupta Kristin Khalaf Gillard Marc K Israel | 2023/8 |
HEART FAILURE OUTCOMES CAPTURED BY ADVERSE EVENT REPORTING IN PARTICIPANTS WITH TYPE 2 DIABETES AND ATHEROSCLEROTIC CARDIOVASCULAR DISEASE: OBSERVATIONS FROM THE VERTIS CV TRIAL | Journal of the American College of Cardiology | Ambarish Pandey Ahmed A Kolkailah Darren K McGuire Robert Frederich Nilo B Cater | 2023/3/7 |
Incident and recurrent hypoglycaemia with linagliptin and glimepiride over a median of 6 years in the CAROLINA cardiovascular outcome trial | Diabetes, Obesity and Metabolism | Julio Rosenstock Ahmed A Kolkailah Darren K McGuire Mark A Espeland Michaela Mattheus | 2023/6 |
Validation of the WATCH‐DM and TRS‐HFDM Risk Scores to Predict the Risk of Incident Hospitalization for Heart Failure Among Adults With Type 2 Diabetes: A … | Journal of the American Heart Association | Matthew W Segar Kershaw V Patel Anne S Hellkamp Muthiah Vaduganathan Yuliya Lokhnygina | 2022/6/7 |
Sodium-glucose cotransporter-2 inhibitors: Impact on atherosclerosis and atherosclerotic cardiovascular disease events | Adam J Nelson Josephine L Harrington Ahmed A Kolkailah Neha J Pagidipati Darren K McGuire | 2022/10/1 | |
Effect of dapagliflozin on hematocrit in patients with type 2 diabetes at high cardiovascular risk: observations from DECLARE-TIMI 58 | Diabetes care | Ahmed A Kolkailah Stephen D Wiviott Itamar Raz Sabina A Murphy Ofri Mosenzon | 2022/2/1 |
Mechanical pulmonic valve thrombosis: Expanding role of cardiac CT and multimodality imaging | Radiology Case Reports | Ahmed A Kolkailah Talal Asif Fady H Iskander Javier Gomez-Valencia Saurabh Malhotra | 2022/9/1 |
Effects of once-weekly semaglutide on coronary outcomes in patients with type 2 diabetes mellitus with or at high risk for cardiovascular disease: insights from the SUSTAIN-6 trial | European Journal of Preventive Cardiology | A Kolkailah A Aharonovich I Lingvay I Dobrecky-Mery S Rasmussen | 2022/5/1 |
The prognostic utility of regadenoson SPECT myocardial perfusion imaging in patients with end-stage renal disease: The largest cohort to date | Journal of Nuclear Cardiology | Ahmed A Kolkailah Mina Iskander Fady Iskander Priya P Patel Rozi Khan | 2022/2/1 |
Trends in oral anticoagulant use among 436 864 patients with atrial fibrillation in community practice, 2011 to 2020 | Journal of the American Heart Association | Ann Marie Navar Ahmed A Kolkailah Robert Overton Nishant P Shah Justin F Rousseau | 2022/11/15 |
Mediators of ertugliflozin effects on heart failure and kidney outcomes among patients with type 2 diabetes mellitus | Diabetes, Obesity and Metabolism | Matthew W Segar Ahmed A Kolkailah Robert Frederich Annpey Pong Christopher P Cannon | 2022/9 |
Co-Authors
